Market Overview:
An immunodeficiency disease occur when immune system of the body fails to carry out its day to day activities of offering protection from various pathogens such as bacteria, virus, parasites, fungus, and others. HIV-AIDS, leukemia, viral hepatitis, and multiple myeloma are some of the immunodeficiency disease and its can be treated by antibiotic therapy, anti-viral drugs, immunoglobulin therapy, stem cell, and gene therapy.
๐๐ก๐ซ๐ข๐ฌ๐ญ๐ฆ๐๐ฌ ๐๐๐ฅ๐ ๐๐ฌ ๐๐ข๐ฏ๐!
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐จ ๐๐ฏ๐๐ข๐ฅ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐ ๐ซ๐จ๐ฆ ๐๐-๐๐% ๐ญ๐ข๐ฅ๐ฅ ๐๐-๐๐๐-๐๐๐๐
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4543
Competitive Landscape:
Pfizer Inc., CSL Behring, Grifols, S.A., Abbott, ADMA Biologics, Inc., AstraZeneca, Baxter, Bayer AG, Biocon, Bristol-Myers Squibb Company, BDI Pharma, Inc., Bharat Serums and Vaccines Ltd., Eli Lilly and Company, GlaxoSmithKline plc., Lupin Pharmaceuticals Inc., Novartis AG, Octapharma AG, Sanofi, and Takeda Pharmaceutical Company Limited
Key Drivers
Growing prevalence of immunodeficiency diseases such as HIV-AIDS, viral hepatitis, leukemia, and multiple myeloma is driving growth of the immunodeficiency therapeutics market. According to the Centers for Disease Control and Prevention, in the United States in 2018, 1,708,921 new cancer cases were reported and 599,265 people died of cancer. For every 100,000 people, 436 new cancer cases were reported and 149 people died of cancer. 2018 is the latest year for which incidence data are available.
Introduction of new and high efficacy immunodeficiency drug is again expected to foster growth of the market. In January 2021, FDA approved CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension), co-packaged for intramuscular use. This is the first FDA-approved injectable, complete regimen for HIV-1 infected adults that is administered once a month.
Covid-19 Impact Analysis
The market of immunodeficiency has witness strong growth during Covid-19 pandemic due to growing need for strong immune system. Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020.
According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 186,240,393 cases and 4,027,861 deaths due to Coronavirus disease (COVID-19) were reported till July 11, 2021, across the globe.
Key Takeaways:
- The immunodeficiency therapeutics market is expected to exhibit a CAGR of 6.1 % over the forecast period owing to the advancement in genetics technology.
- North America is expected to witness significant growth over the forecast period owing to the growing research and development activities by the market players. For instance, in November 2020, AscellaHealth announces the launch of its Intravenous Immunoglobulin (IVIG) Medication Therapy Management Program to support the mission of the Immune Deficiency Foundation (IDF), Jeffrey Modell Foundation (JMF) and the primary immunodeficiency disease (PIDD) community.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4543
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Distribution Chanel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Industry Trends
- Pipeline Analysis
- Key Highlights
- Epidemiology
- Pricing List
- Regulatory Scenario
- Global Supply Chain Analysis
- Market Dynamics
- Global Immunodeficiency Therapeutics Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Immunodeficiency Therapeutics
- Impact of Covid-19 on the Immunodeficiency Therapeutics Market
- Global Immunodeficiency Therapeutics Market, By Therapy Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Immunoglobulin Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Antibiotics Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Stem Cell and Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Immunodeficiency Therapeutics Market, By Test Type, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Blood Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Immunodeficiency Therapeutics Market, By Disease Type, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Antibody Deficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Cellular Immunodeficiency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Innate Immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Immunodeficiency Therapeutics Market, By Distribution Channel, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Immunodeficiency Therapeutics Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2028
- Regional Trends
- North America
- Market Size and Forecast, By Therapy Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Therapy Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Test Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Disease Type, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 – 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4543
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837